Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist

The physiologic properties of glucagon-like peptide 1 (GLP-1) make it a potent candidate drug target in the treatment of type 2 diabetes mellitus (T2DM). GLP-1 is capable of regulating the blood glucose level by insulin secretion after administration of oral glucose. The advantages of GLP-1 for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ying, Zheng, Xuemin, Yi, Xiulin, Liu, Changxiao, Kong, Dexin, Zhang, Jianning, Gong, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Federation of American Societies for Experimental Biology 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434659/
https://www.ncbi.nlm.nih.gov/pubmed/28270518
http://dx.doi.org/10.1096/fj.201601339R

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434659/
https://www.ncbi.nlm.nih.gov/pubmed/28270518
http://dx.doi.org/10.1096/fj.201601339R

Ejemplares similares